Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

PMCB

PharmaCyte Biotech, Inc.

CIK 0001157075 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$0.70
↓ 0.01 (-1.42%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$7.51M
P/E Ratio
-2.29
EPS
3.19
Dividend Yield
Not covered
52W Position
8%
Beta
1.33

Valuation multiples

Fwd P/E
7.02
PEG
0.00
P/B
0.20
P/S
Not covered
EV/Revenue
Not covered
ROE
-8.6%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 8%
$0.63$1.51

Latest Financials

2025-04-30 FY
Revenue
$0.00
Net Income
$30.66M
Total Assets
$55.17M
Free Cash Flow
–

Recent news